Psychoactive Drugs, Tolerance, and Withdrawal

Psychoactive drugs work by hijacking normal neurotransmission. Stimulants like cocaine and amphetamines increase neural activity, often by boosting dopamine and norepinephrine, which is why they raise alertness, energy, and mood. Depressants like alcohol and benzodiazepines slow activity down, typically by enhancing GABA, the brain's main inhibitory neurotransmitter, producing relaxation and sedation. Opioids like heroin and morphine bind to receptors that normally respond to the body's own endorphins, blunting pain and producing euphoria. Hallucinogens like LSD disrupt normal sensory and perceptual processing, often acting on serotonin receptors, which is why they distort perception rather than simply speeding up or slowing down the brain.

Tolerance builds because the brain does not just sit there and absorb a drug's effects passively. With repeated exposure, it adjusts its own chemistry to compensate, for example producing less of a neurotransmitter naturally, or reducing the number or sensitivity of receptors, to counteract the drug's push. That adjusted baseline is why the same dose stops producing the same effect over time, and why users need more of the drug just to feel normal, let alone high.

This adapted baseline is also the key to understanding withdrawal. Withdrawal is not simply the drug leaving the system and its effects fading out. It is the exposed, unsupported baseline reasserting itself, which is why withdrawal symptoms often look like the opposite of the drug's effects: a stimulant user crashes into exhaustion and depression, a depressant user becomes anxious and agitated. This same logic explains relapse risk, connecting directly to how tolerance can quietly reverse during abstinence.